Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,723Revenue (TTM) $M383Net Margin (%)-3.6Altman Z-Score8.8
Enterprise Value $M1,674EPS (TTM) $-0.2Operating Margin %-3.7Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-4.0Higher ROA y-yN
Price/Book8.110-y EBITDA Growth Rate %--Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.45-y EBITDA Growth Rate %19.4Current Ratio3.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-27.9ROA % (ttm)-4.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-6.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M66.2ROIC % (ttm)-8.8Gross Margin Increase y-yY

Gurus Latest Trades with NXTM

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NXTM is held by these investors:



NXTM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Swan Winifred LSVP and General Counsel 2017-11-15Sell3,500$25.731.13view
TOWSE MATTHEW WSVP and Chief Financial Office 2017-10-20Sell4,030$27.5-5.38view
Swan Winifred LSVP and General Counsel 2017-10-20Sell3,500$27.5-5.38view
Turk Joseph E JrPresident 2017-10-04Sell1,000$27.56-5.59view
Swan Winifred LSVP and General Counsel 2017-09-20Sell3,500$27.27-4.58view
TOWSE MATTHEW WSVP and Chief Financial Office 2017-09-20Sell4,300$27.27-4.58view
Turk Joseph E JrPresident 2017-09-05Sell1,000$27.95-6.91view
TOWSE MATTHEW WSVP and Chief Financial Office 2017-08-21Sell4,300$29.22-10.95view
Swan Winifred LSVP and General Counsel 2017-08-15Sell3,500$29.21-10.92view
Turk Joseph E JrPresident 2017-08-10Sell1,000$29.26-11.07view

Quarterly/Annual Reports about NXTM:

News about NXTM:

Articles On GuruFocus.com
Report: Exploring Fundamental Drivers Behind Vantiv, Nxstage Medical, Newell Brands, Nordstrom, Newm Nov 06 2017 
Eleven Unique NxStage Abstracts Accepted for 2017 Kidney Week Nov 01 2017 
NxStage Announces Stockholder Approval Of Merger Agreement With Fresenius Medical Care Oct 27 2017 
NxStage Announces Winners of Third Annual Nurse Hero Award Oct 18 2017 
Jeffrey H. Burbank Joins CryoLife Board of Directors Oct 02 2017 
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Nxstage Medical, Inc. - Sep 10 2017 
NxStage Medical Announces FDA Clearance for Solo Home Hemodialysis Using NxStage® System One™ Aug 28 2017 
NxStage System One Now in Nine of Top Ten U.S. Nephrology Hospitals Aug 24 2017 
NXSTAGE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investiga Aug 14 2017 
NxStage Kidney Care and Dialyze Direct to Provide On-Site Dialysis to Skilled Nursing Facility Patie Aug 11 2017 

More From Our Partners
Here's Why You Should Offload Fresenius Medical Stock Now Nov 22 2017 - ZACKS
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK